9788419284624_Sadhu. MW Cardiología 4ed

65

Capítulo 5 Paciente cardíaco sometido a cirugía no cardíaca

5. Davenport DL, Ferraris VA, Hosokawa P, Henderson WG, Khuri SF, Mentzer RM Jr. Multivariable predictors of postoperative cardiac adverse events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg . 2007;204:1199-210. 6. Gupta PK, Gupta H, Sundaram A, et al. Development and validation of a risk calculator for predic tion of cardiac risk after surgery. Circulation . 2011;124:381-7. 7. Wijeysundera DN, Duncan D, Nkonde-Price C, et al. Perioperative beta-blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evalu ation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines . J Am Coll Cardiol . 2014;130:2246-64. 8. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet . 2008;371:1839-47. 9. Levine GN, Bates ER, Bittle JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease. J Am Coll Cardiol . 2016;68:1082-1115. 10. Riddell JW, Chiche L, Plaud B, Hamon M. Coronary stents and noncardiac surgery. Circulation . 2007;116:e378-82. 11. Capodanno D, Alfonso F, Levine GN, Valgimigli M, Angiolillo DJ. ACC/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison. J Am Coll Cardiol . 2018;72(23 Pt A):2915-31. 12. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med . 2004;351:2795-804.

SAMPLE